📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance. (2023)

First Author: Nicolescu RCB

Attributed to: Diversity-Oriented Synthesis of Stapled Peptides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cmdc.202200548

PubMed Identifier: 36300876

Publication URI: http://europepmc.org/abstract/MED/36300876

Type: Journal Article/Review

Volume: 18

Parent Publication: ChemMedChem

Issue: 2

ISSN: 1860-7179